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 The objective of this study is to evaluate the activity of gelatin hydrogels 
incorporating combined stromal cell-derived factor-1 (SDF-1) and bone morphogenetic 
protein-2 (BMP-2) on the in vivo bone regeneration at an ulna critical-sized defect and 
subcutaneous site of rats, and compared with that of those incorporating either SDF-1 or 
BMP-2. The similar release profile of SDF-1 and BMP-2 from the hydrogels was observed 
with or without the combination of BMP-2 and SDF-1, respectively. An enhanced bone 
regeneration by the hydrogels incorporating combined SDF-1 and BMP-2 was observed. In 
addition, the implantation of hydrogels incorporating combined SDF-1 and BMP-2 enhanced 
the expression level of CXC chemokine cell-surface receptor-4 (Cxcr4), Runt-related factor-2 
(Runx2), and Osteocalcin genes. The experiments with green fluorescent protein (GFP)-
positive Chimeric mice revealed that the recruitment of bone marrow-derived cells was 
promoted and a vascular-like structure together with strong accumulation of CD31- and 
CD34-positive cells was observed at the site of hydrogels incorporating combined SDF-1 and 
BMP-2 implanted. In addition, a large fraction of CD29- and CD44-positive non-
hematopoietic cells was detected. It is concluded that the combined release of SDF-1 and 
BMP-2 enhanced the recruitment of osteogenic cells and angiogenesis, resulting in the 
synergistic effect on bone regeneration. 
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Tissue engineering is a newly emerging biomedical technology to promote the cell 
potentials of proliferation and differentiation and has been extensively studied to induce the 
regeneration and repairing of defective tissues over last 20 years. Many researches have been 
attempted to design the substitutes of natural microenvironment by providing the components 
of extracellular matrix (ECM), growth factors, cells, and the combination in different 
manners [1]. For bone tissue engineering, the combination of these multiple cues is required 
since the mechanism of bone repairing is complex and regulated by many factors, including 
the characteristics of ECM scaffolds, the type of angiogenic and osteogenic growth factors, 
and the osteogenic potential of cells [2]. In addition to tissue engineering-based regeneration 
therapy, the transplantation of various cells has been performed experimentally and clinically. 
However, the cell transplantation does not always obtain the good result of tissue 
regeneration because of the limitations of cell source, the low survival rate of cells 
transplanted [3,4], and the immunogenic responses of transplanted vs. host cells [5]. Also, the 
nature of cells cultured for transplantation might not be equal to that of cells present in the 
body. In this situation, recently, the body cells are focused as a potential source for tissue 
regeneration. Some researches have demonstrated that stem cells originating in the blood 
circulation play a crucial role in hematopoiesis, vascularization or mesenchymal tissue 
regeneration [6,7]. It is reported that bone marrow-derived osteoblast progenitor cells present 
in the circulating blood participated in BMP-2-induced ectopic bone formation [8,9]. The 
research gives us an idea that the appropriate supply of growth factors in a suitable fashion is 
effective in recruiting host circulating stem cells to the defect site, biologically functioning 
thereat, and inducing the bone regeneration.   
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To achieve the recruitment of host circulating cells, stromal cell-derived factor-1 
(SDF-1), scientifically designated as Chemokine (C-X-C motif) ligand 12 (CXCL12), was 
selected in this study. It is known that SDF-1 is critical to induce the natural migration and 
homing of stem cells to a targeted site within the body [10]. SDF-1 is also involved in the 
recruitment of inflammatory cells and stem cells committed to other types of tissue [11]. It is 
reported that SDF-1 mediates the homing of cells by binding to a G protein-coupled receptor, 
CXCR4, on the surface of circulating CXCR4-positive progenitor cells [12,13]. Aiuti et al. 
[14] have introduced that the SDF-1/CXCR4 interaction involved in the mobilization of 
CD34-positive progenitors to the peripheral blood circulation and in the homing of 
hematopoietic stem cells to their specific niches. Some researches have reported on the role 
of SDF-1 in the mobilization and recruitment of circulating bone marrow-derived 
hematopoietic (HSC) and mesenchymal stem cells (MSC), which contribute to cell-based 
vascularization and bone regeneration [15-17]. Our recent study has also demonstrated that a 
dose of SDF-1 released from gelatin hydrogels enhanced angiogenesis at the site implanted 
because of the enhanced recruitment of cells which are effective in angiogenesis [18]. 
Among osteogenic growth factors, bone morphogenetic protein-2 (BMP-2) is well-
known as a strong inducer of bone tissue formation by enhancing the recruitment of 
osteoblast progenitor cells [8], angiogenesis [19], and promoting the osteogenic 
differentiation of mesenchymal stem cells [20,21]. The BMP-2 treatment induced complete 
bone regeneration at a bone defect [22] and formed bone tissues ectopically for the animal 
models [8,9]. In addition, it has an activity to enhance the cells mobilization and homing to 
the defect site [8]. Our previous study experimentally confirmed with the green fluorescent 
protein
 
(GFP)-positive Chimeric mice that the recruitment of bone marrow-derived cells to 




































































phenomenon demonstrates ectopic bone formation due to the accumulation of osteogenic 
cells.  
Angiogenesis is important for the process of bone regeneration and the combination 
of angiogenic factors further enhanced the bone regeneration induced by osteogenic factors 
[23,24]. Based on these findings, we hypothesized that a local release of combined SDF-1 
and BMP-2 may facilitate the recruitment of host circulating stem cells to the site implanted, 
and achieve the consequent angiogenesis and bone regeneration. To this end, the controlled 
release system to prolong the in vivo half-life of growth factors is required [25]. In this study, 
gelatin hydrogels were selected as the controlled release carriers since our previous 
researches confirm that the controlled release of SDF-1 and BMP-2 from gelatin hydrogels 
successfully induced angiogenesis and bone regeneration, respectively [9,18]. The potential 
of combined SDF-1 and BMP-2 release from the gelatin hydrogels to induce bone 
regeneration has not been investigated yet.  
This study is undertaken to evaluate the bone regeneration of gelatin hydrogels 
incorporating combined SDF-1 and BMP-2, comparing with that of hydrogels incorporating 
either SDF-1 or BMP-2. Bone regeneration was investigated at an ulna critical-sized defect 
and ectopically the back subcutis of rats in terms of radiological, micro-computed 
tomography (µCT), peripheral quantitative computed tomography (pQCT), and histological 
examinations. In addition, the expression of osteogenic genes of cells in the hydrogels 
implanted was evaluated to compare it among the different hydrogels incorporating SDF-1, 
BMP-2, and the combination. We also examined the recruitment of GFP-positive-bone 
marrow-derived mesenchymal stem cells and endothelial positive cells into the site of 
hydrogels implanted. In addition, the number of live cells and the fraction type of non-





































































2. Materials and Methods 
 
2.1 Materials 
A gelatin sample prepared by an acidic treatment of porcine skin collagen (isoelectric 
point (IEP) = 9.0) was kindly supplied by Nitta Gelatin Inc., Osaka, Japan. Recombinant 
human stromal cell-derived factor-1 (SDF-1, 350-NS/CF) was obtained from R&D systems 
Inc., Minneapolis, MN. Recombinant human bone morphogenetic protein -2 (BMP-2) was 
kindly supplied from Yamanouchi Pharmaceutical Co., Tokyo, Japan. Na
125
I (NEZ-033H, 





I] Bolton-Hunter reagent (NEX-120H, 147 MBq/ml) were purchased from Perkin-Elmer 
Life Sciences Inc., Boston, MA. Glutaraldehyde (GA), glycine, and other chemicals were 
obtained from Wako Pure Chemical Industries, Ltd., Osaka, Japan and used without further 
purification. All primers (Table 1) were purchased from Invitrogen Corporation, Ltd., 
Carlsbad, CA.  
 
2.2 Preparation of gelatin hydrogels 
 Chemically-crosslinked gelatin hydrogels with GA were prepared according to the 
method previously reported [9,18]. Briefly, gelatin aqueous solution (5 wt%, pH 5.0) was 
mixed with GA at a final concentration of 0.16 wt%, followed by leaving at 4 °C for 12 hr to 
allow gelatin crosslinking. The crosslinked gelatin hydrogels were treated with 0.1 M glycine 
solution to block the residual aldehyde groups. After three-time washing with double-distilled 
water (DDW), the hydrogels were freeze-dried. The hydrogels were sterilized by ethylene 
oxide before every experiment in this study. According to our previous researches, the water 
content of gelatin hydrogels prepared was 98.2 ± 0.1 wt% and the in vivo degradation time 




































































2.3 Isolation and culture of rat bone marrow-derived mesenchymal stem cells 
Bone marrow-derived mesenchymal stem cells (MSC) were isolated from the bone 
shaft of femurs of 3-week-old Wistar rats according to the procedure reported previously 
[26]. Briefly, after cutting off both ends of rat femurs, the bone marrow was flushed out with 
1 ml of Alpha-modified Eagle minimal essential medium (α-MEM). Then, the bone marrow 
cells mixture was cultured in α-MEM supplemented with 15 vol% fetal bovine serum (FBS), 
and 100 U/ml penicillin and streptomycin at 37 C in a 5% CO2-95% air atmospheric 
condition. The medium was refreshed on the 4
th
 day after isolation to remove non-adherent 
cells and continuous refreshed every 3 days thereafter. The cells of the second- and third-
passages at the subconfluent condition were used for the following experiments. 
 
2.4 In vitro MSC cultures with SDF-1 and BMP-2 and their functional evaluation  
MSC were seeded onto 6-cm tissue culture plates (CORNING 430166, Corning Inc., 
Cambridge, MA) at 10
5
 cells/plate and cultured for 24 hr in the α-MEM containing 15 vol% 
FBS, and 100 U/ml penicillin and streptomycin at 37 C in a 5% CO2-95% air atmospheric 
condition. Then, the medium was changed to the α-MEM containing 0.5 vol% FBS and 500 
ng/ml of SDF-1, combined SDF-1 and BMP-2 at concentration ratios of 500/300, 400/400, 
and 300/500 ng/ml or 300 ng/ml of BMP-2. The cells were cultured in α-MEM containing 0.5 
vol% FBS as a control. After 24 hr culture, cells were collected, washed with 100 mM of 
phosphate-buffered saline solution (PBS, pH 7.4), and the total RNA was extracted by using 
RNeasy® Plus Mini kit (Qiagen, Valencia, CA) according to the manufacturer’s instructions. 
Reverse transcription reaction was performed with the SuperScript II First-Stand Synthesis 
System (Invitrogen Corporation, Ltd., CA). Real-time polymerase chain reaction (PCR) was 
performed on a Prism 7500 real time PCR thermal cycler (Applied Biosystems, Foster City, 




































































Master Mix (Applied Biosystems) and 10 μM of each primer (Table 1) to analyze the 
expression level of CXC chemokine cell-surface receptor-4 (Cxcr4) and Runt-related factor-2 
(Runx2). The reaction mixture was incubated for the initial denaturation at 95 C for 10 min, 
followed by 40 PCR cycles. Each cycle consisted of the following three steps; 94 C for 15 
sec, 57 C for 15 sec and 72 C for 1 min. Each mRNA level was normalized by the 
expression level of 18S ribosomal RNA as an internal control. The activity of alkaline 
phosphatase (ALP) for cells cultured similarly was assayed by p-nitrophenyl phosphate 
method 3 days after culture [26]. Each experiment was independently performed for 3 
samples. 
Gelatin hydrogels (1 x 6 x 6 mm
3
) incorporating PBS, 500 ng of SDF-1, 500 ng of 
SDF-1 and 300 ng of BMP-2, and 300 ng of BMP-2 were prepared by dropping the solution 
(20 µl) onto the hydrogel freeze-dried, followed by leaving at 4 C overnight to allow the 
solution incorporation. Next, 50 µl of cell suspension (10
6
 cells) was seeded into each 
hydrogel for 6 hr by the agitation seeding technique reported previously [26]. Then, 1 ml of 
α-MEM containing 0.5 vol% FBS was added into each cells-seeded hydrogel and the cells 
were cultured for 3 days without further medium change. The hydrogels were collected, 
washed with PBS, and the total RNA was extracted by using RNeasy® fibrous tissue mini kit 
(Qiagen, Valencia, CA) according to the manufacturer’s instructions. The RT-PCR assay was 
performed as described previously to evaluate the expression level of Cxcr4 and Runx2 genes 
of MSC cultured in the hydrogels.  
 
2.5 In vivo release test of SDF-1 and BMP-2 from gelatin hydrogels 
SDF-1 and BMP-2 were radioiodinated according to the conventional chloramine T 
method as previously described [27]. Briefly, 5 μl of Na125I was added into 200 μl of SDF-1 




































































containing 0.5 M NaCl. Then, 100 μl of the same buffer containing 0.2 mg/ml chloramine-T 
was added to the solution mixture. After vortex mixing at room temperature for 2 min, 100 μl 
of PBS containing 0.4 mg sodium metabisulfate was added to the reacting solution to stop the 
radioiodination. The solution mixture was passed through a PD-10 desalting column (GE 
Healthcare Life Sciences, Chalfont St Giles, UK) to remove the uncoupled, free 
125
I 
molecules from the 
125
I-labeled SDF-1 or 
125
I-labeled BMP-2 using PBS as an eluting 
solution. PBS solution containing 
125
I-labeled SDF-1 (4.3 µg/ml) or 
125
I-labeled BMP-2 (13.7 
µg/ml) was mixed with PBS containing non-labeled SDF-1 or BMP-2 to give the final 
concentrations of 232 and 202 µg/ml, respectively. The mixed solution containing 5 µg of 
SDF-1 and/or 3 µg of BMP-2 (20 µl) was then adsorbed onto a freeze-dried gelatin hydrogel 
(1 x 6 x 6 mm
3
), followed by leaving at 4 C overnight to obtain hydrogels incorporating 125I-
labeled SDF-1 or 
125
I-labeled BMP-2. The hydrogel samples used for the in vivo release test 
are gelatin hydrogels incorporating 5 µg of
 125
I-labeled SDF-1, 5 µg of 
125
I-labeled SDF-1 
and 3 µg of non-labeled BMP-2, 5 µg of non-labeled SDF-1 and 3 µg of 
125
I-labeled BMP-2, 
and 3 µg of 
125
I-labeled BMP-2. Following the implantation into the back subcutis of 6-week-
old female C57BL/6 mice, the hydrogels were taken out at different time intervals to count 
the radioactivity remaining by the gamma counter (Auto Well Gamma System ARC-380 CL, 
Aloka Co., Ltd, Tokyo, Japan). Each experiment was independently performed for 3 samples 
at each sampling time. 
 
2.6 In vivo degradation test of gelatin hydrogels 
To evaluate the in vivo degradation profile of gelatin hydrogels, the implantation of 
125
I-labeled hydrogels was performed according to the method previously reported [18]. 
Briefly, 20 μl of [125I]Bolton–Hunter reagent solution in benzene was completely evaporated 




































































resulting solution (20 μl) was adsorbed onto a freeze-dried gelatin hydrogel, followed by 
leaving at 4 C overnight to introduce 125I into the amino groups of gelatin. The 
radioiodinated hydrogels were washed with DDW thoroughly to exclude the uncoupled, free 
125
I molecules till to make the DDW radioactivity to the background level. Following the 
implantation into the back subcutis of mice, the hydrogels were taken out at different time 
intervals to count the radioactivity remaining by the gamma counter. Each experiment was 
independently performed for 3 samples at each sampling time. 
 
2.7 Evaluation of in vivo bone regeneration at ulna critical-sized defect 
A bone defect model of rat ulna was prepared to evaluate the bone regeneration of 
hydrogels incorporating SDF-1 and/or BMP-2. The surgery was made for 12-week-old male 
Wistar rats (n = 12) under standard sterile conditions according to the procedure previously 
reported [28]. Briefly, the rats were anesthetized with an intraperitoneal injection of 
pentobarbital sodium solution (35-40 mg/kg body weight). After shaving the hair and 
disinfection with 70 vol% ethanol, a longitudinal incision was made along the forearm skin of 
rats. The periosteum was incised circumferentially to approach to the ulna bone. A critical 
defect of 6 mm length was then created at the middle position of ulna bone using a side-
cutting diamond disk and a high-speed micromotor under an abundant irrigation with sterile 
saline solution [29]. The hydrogels were implanted into the defects while the periosteum and 
overlying muscle were repositioned with an absorbable polydioxanone suture (Ethicon 7-0, 
NJ). Then, the wound was closed with a non-absorbable polypropylene suture (Ethicon 4-0, 
NJ). All the animal experiments were performed according to the Institutional Guidance of 
Kyoto University on Animal Experimentation and under permission by animal experiment 
committee of Institute for frontier Medical Science, Kyoto University. The hydrogel samples 
used for the defect experiment are gelatin hydrogels incorporating PBS, 5 µg of
 




































































of SDF-1 and 3 µg of BMP-2, and 3 µg of BMP-2.  Each rat received the implantation of 2 
hydrogels randomly in both left and right of forearm’s ulna. Each experiment was 
independently performed for 6 samples. 
 
2.8 Evaluation of in vivo ectopic bone formation at back subcutis  
Ectopic bone formation by gelatin hydrogels incorporating SDF-1 and/or BMP-2 was 
assessed for 12-week-old male Wistar rats (n = 12) under standard sterile conditions. Briefly, 
the rats were anesthetized, shaved the hair, and disinfected with 70 vol% ethanol. A vertical 
incision was created down the midline of the back. The hydrogels (1 x 6 x 6 mm
3
) were 
inserted subcutaneously away from the incision. The wound was sutured and disinfected with 
betadin. The 4 types of hydrogels similar to the bone defect model were randomly implanted. 
To evaluate gene expression by the RT-PCR assay, the hydrogels implanted were taken out 
with a surgical scalpel. The total RNA was extracted by using RNeasy fibrous tissue mini kit 
(Qiagen, Valencia, CA) according to the manufacturer’s instructions. The RT-PCR assay was 
performed as described previously to evaluate the expression level of Cxcr4 and Runx2 genes 
of cells in the hydrogels implanted. Expression level of Cxcr4 gene was assessed 3 days after 
implantation, and that of Runx2 and Osteocalcin genes of osteogenic marker was done 2 and 
4 weeks after implantation. 
 
2.9 Radiological and histological examinations of bone tissue regenerated  
 The bone tissue regenerated at the defect and subcutaneous site, 4 weeks later, were 
radiologically examined by the soft x-ray machine (Hitex-100, Hitachi Ltd., Tokyo, Japan) at 
56 kV and 2.5 mA for 20 sec. Then, the samples were fixed with 3 wt% paraformaldehyde in 
PBS at room temperature for 48 hr, decalcified with PBS containing 9 wt% ethylenediamine 




































































(EDTA) solution at room temperature for 7 days. The EDTA solution was changed every 
other day. After decalcification, the samples were equilibrated in PBS containing 15 wt% 
sucrose for 24 hr, and then in PBS containing 30 wt% sucrose for further 24 hr, embedded in 
Tissue-Tek OCT Compound (Sakura Finetek Inc., Tokyo, Japan), and frozen on liquid 
nitrogen. For the histological examination, the 6 µm-thick sections were cut at the center of 
samples, followed by staining with hematoxylin and eosin (H&E) and Masson trichrome to 
observe the cell infiltration and collagen newly formed. The images were taken under a 
microscope (AX80 Provis, Olympus Ltd., Tokyo, Japan) and the area percentage of matured 
collagen to collagen newly formed was measured by Image J software (Version 1.41, Java™, 
USA) from each image (20X magnification) randomly selected. Each measurement was 
performed for 6 images. 
 
2.10 Micro-computed tomography (µCT) and peripheral quantitative computed tomography 
(pQCT) scan examinations of bone regenerated  
Three-dimensional images of bone regenerated in the ulna defects were visualized 
with the CT scans (X-RAY CT System, SMX-100CT-SV3 TYPE, Shimadzu Ltd., Kyoto, 
Japan). Samples were scanned over a fixed length of bone with a 20 mm sample holder at a 
resolution of 20 μm, energy of 30 kV, current of 25 μA, and exposure time of 300 ms. The 2-
dimensional images were reconstructed and submitted to the VGStudio MAX 1.2 software 
(Volume Graphics GmbH, Heidelberg, Germany) for processing to produce the 3-
dimensional images of bone regenerated. The bone mineral density (BMD) of whole cortical 
compartment of bone tissue regenerated was analyzed by using a highly accurate multi-slice 
pQCT (XCT Research SA+, Stratec Medizintechnik, GmbH, Pforzheim, Germany) at a 
resolution of 0.08 m voxel size and a threshold value of 267 mg/cm
3
 with a scanning protocol 




































































Analysis of the regional cortical BMD was carried out for each of 3 tomographic slices at a 
square region of interest (ROI) generated. 
 
2.11 Evaluation of bone marrow-derived cells recruitment to gelatin hydrogels with GFP-
positive Chimeric model 
C57BL/6 transgenic mice that ubiquitously express enhanced green fluorescent 
protein (GFP) under the Cytomega-lovirus (CMV) early enhancer/chicken β actin (CAG) 
promoter were provided by the RIKEN BioResource Center (Tsukuba, Japan) through the 
National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and 
Technology (MEXT, Japan). Chimeric mice were prepared according to the procedure 
reported previously [9,17]. Briefly, 8- to 10-week-old female C57BL/6 mice were irradiated 
lethally with 10 Gy of gamma-ray. For the total bone marrow transplantation (BMT), 5 x 10
6
 
of bone marrow cells prepared from 8- to 10-week-old male GFP transgenic mice was 
intravenously administered to recipient irradiated mice [30]. After the transplantation, the 
mice were bred for 5 months to complete the replacement of bone marrow-derived cells to 
GFP-positive cells. The replacement ratio of GFP-positive-bone marrow-derived cells was 
98.1 ± 2.8 % when evaluated by the fluorescence-associated cell sorter method (FACS 
Calibur, BD Bioscience Ltd., Franklin Lakes, NJ). 
 Various gelatin hydrogels were subcutaneously implanted into the back of Chimeric 
mice in the similar procedure mentioned above. The hydrogels including the surrounding 
tissue were extracted 2 and 4 weeks post-operatively, and the fluorescent images were taken 
by a digital microscope (AxioCam MRc 5, Carl Zeiss Inc., Jena, Germany). For 
immunohistochemistry staining, the hydrogel samples were fixed with 3 wt% 
paraformaldehyde in PBS at 4 C for 24 hr, equilibrated in PBS containing 15 wt% sucrose at 




































































samples were embedded and sectioned (8 µm thickness) as described above. To stain 
osteocalcin-positive cells, the sections were washed with PBS, blocked with a normal goat 
serum for 1 hr at room temperature before incubation with a rabbit polyclonal anti-mouse 
osteocalcin antibody (1:250; Takara Bio Inc., Shiga, Japan) for 1 hr at room temperature. 
Then, the sections were stained with a Alexa Flour 546-conjugated goat anti-rabbit IgG (8 
µg/ml, Invitrogen Corporation, Ltd., CA) for 45 min at room temperature and cell nuclei 
were finally stained with Hoechst 33258 (Nacalai Tesque Inc., Kyoto, Japan). After washing, 
the sections were mounted with Vectashield® (Vector Laboratories, Burlingame, CA). The 
fluorescence images were taken on a fluorescent microscope (Apotome, Imager.Z1, Carl 
Zeiss, Jena, Germany).  
For the immunohistochemical staining with CD31 and CD34 of endothelial marker, 
the sections were incubated with a fluorescein isothiocyanate (FITC) anti-mouse CD31 
(1:100, BioLegend Inc., CA) or a FITC anti-mouse CD34 (1:100, BD Biosciences 
Pharmingen Inc., CA) for 1 hr at room temperature. After washing, the sections were stained 
with a Simple Stain Mouse MAX-PO (Histofine®, Nichirei Biosciences Inc., Tokyo, Japan) 
for 45 min at room temperature. For bright-field microscopy, bound primary antibodies were 
detected using DAKO EnVision- Horseradish Peroxidase and 3, 3'-diaminobenzidine (DAB) 
substrate kit (Vector Laboratories, Burlingame, CA), and counter-stained with Hematoxylin 
to visualize the cell nuclei. Then, the sections were mounted with an aqueous mounting 
medium (MGK-S, Matsunami Glass Ind. Ltd., Osaka, Japan) and the images were taken on a 







































































2.12 Evaluation of the fraction type of non-hematopoietic stem cells in gelatin hydrogels 
implanted by flow cytometry 
 The fraction type of non-hematopoietic stem cells in gelatin hydrogels incorporating 
SDF-1 and/or BMP-2 implanted was analyzed by flow cytometry after staining with 3 
monoclonal antibodies including anti-CD29, anti-CD44, and anti-CD45 (BioLegend Inc., 
CA) [31]. Similarly to the in vivo experiments described above, various gelatin hydrogels 
were subcutaneously implanted into the back of 6-week-old female C57BL/6 mice. The 
hydrogels were taken out 4 weeks post-operatively, minced into small pieces, and incubated 
in collagenase solution (400 units/ml) at 37 C for 40 min for tissue digestion. The tissues 
remained were separated from cells by using cell strainer (70 µm, BD Falcon
TM
, BD 
Biosciences Inc., MA) and the cells were collected by centrifugation at 2,000 rpm, 4 C, and 
5 min (Microcentrifuge 5417R, Eppendorf, Hamburg, Germany). Then, the cells were 
washed with PBS, blocked with 2.4G2 (anti-FcRII/III) antibody on ice for 15 min, and 
stained with monoclonal antibodies in PBS containing 2 vol% FBS and 0.1 vol% sodium 
azide on ice for 15 min. Propidium iodide was used to distinguish dead cells from viable 
cells. The cells immunostained were analyzed on FACSCanto II flow cytometer (BD 
Biosciences Inc., MA). Analysis was performed by BD FACSDiva software (BD Bioscience 
Inc., MA) and FLOWJO software (Tree Star, San Carlos, CA). Each analysis was performed 
for 3 samples. 
 
2.13 Statistical analysis 
All the results were statistically analyzed by the unpaired student’s t test and p < 0.05 








































































3.1 Gene expression of MSC cultured with SDF-1 and/or BMP-2 
 Figures 1A and B show the expression level of Cxcr4 and Runx2 genes for MSC 
cultured with SDF-1 and BMP-2 at different mixing ratios. Irrespective of the mixing ratio, 
combined SDF-1 and BMP-2 or BMP-2 alone significantly up-regulated the Cxcr4 and 
Runx2 expression. On the other hand, the expression level of SDF-1-incubated cells was 
similar to that of non-treated MSC. Figure 1C shows the ALP activity of MSC cultured with 
SDF-1 and/or BMP-2. The effect of SDF-1 and BMP-2 on the ALP activity was similar to 
that of gene expressions, though MSC cultured with SDF-1 showed a significant increase in 
the ALP activity compared with the non-treated MSC.  
 Figures 2A and B show the expression level of Cxcr4 and Runx2 genes for MSC 
cultured in the gelatin hydrogels incorporating SDF-1 and/or BMP-2. MSC cultured in the 
gelatin hydrogels incorporating combined SDF-1 and BMP-2 or BMP-2 showed significantly 
up-regulated expression of both Cxcr4 and Runx2 genes. A significant higher level of Runx2 
expression of MSC cultured in the hydrogels incorporating combined SDF-1 and BMP-2 than 
that of the hydrogels incorporating BMP-2 was observed. 
 
3.2 Controlled release of SDF-1 and BMP-2 from gelatin hydrogels and hydrogel 
degradation 
 Figure 3A shows the time profiles of SDF-1 and BMP-2 released from gelatin 
hydrogels. An initial burst in SDF-1 release was seen for the first day, and 70 and 80 % of 
radioactivity were released out from the hydrogels incorporating SDF-1 and combined SDF-1 
and BMP-2, respectively. Within the first 3 days, the SDF-1 release was significantly 




































































release test. On the contrary, irrespective of the SDF-1 combination, BMP-2 showed less 
burst release than SDF-1 and the radioactivity remaining were around 55 and 45 % for the 
hydrogels incorporating BMP-2 and combined SDF-1 and BMP-2, respectively. At 14 days, 
about 10-15 % of SDF-1 was remained in the hydrogels, while the percent remaining of 
BMP-2 was approximately 22 %. After 28 days, the radioactivity of SDF-1 and BMP-2 
remained in every hydrogel was around 5-10%. On the other hand, gelatin hydrogels were 
gradually degraded over 28 days. Figure 3B shows the relationship of remaining radioactivity 
between SDF-1 or BMP-2 incorporated in gelatin hydrogels and the hydrogels of release 
carriers. Irrespective of the type of growth factors, a linear relationship of remaining amount 
between SDF-1 or BMP-2 and the hydrogels was observed. The time profiles of SDF-1 and 
BMP-2 release were correlated well with the degradation of the hydrogels (R
2
  0.93).      
 
3.3 Bone regeneration in an ulna critical-sized defect 
 Figure 4 shows the soft x-ray and histological images of bone regenerated. New bone 
tissues were regenerated in the defects implanted with the hydrogels incorporating combined 
SDF-1 and BMP-2 or BMP-2, although the extent of the former was greater than that of the 
latter. On the contrary, bone regeneration was not observed in the defects implanted with the 
hydrogels incorporating SDF-1 or PBS. Similarly to soft x-ray images, histological sections 
showed abundant collagen formation for the hydrogels incorporating SDF-1 and BMP-2 or 
BMP-2. On the contrary, a slight formation of collagen was observed in the defect implanted 
with the hydrogels incorporating SDF-1 or PBS.  
Figures 5A and B show the µCT images of bone regenerated in the defects implanted 
with the hydrogels incorporating combined SDF-1 and BMP-2 or BMP-2. For both groups, 
the bone union was formed. A new bone was regenerated from the edge toward the center of 




































































shows the pQCT analysis data. A significantly higher BMD was found in the bone 
regenerated by the hydrogels incorporating combined SDF-1 and BMP-2 than that of the 
hydrogels incorporating BMP-2. 
 
3.4 Gene expression of cells in the hydrogels incorporating SDF-1 and/or BMP-2 implanted 
 Figure 6A shows the expression level of Cxcr4 gene of cells in the hydrogels 
subcutaneously implanted. The presence of SDF-1 and BMP-2 enhanced the level of Cxcr4 
gene compared with the hydrogels incorporating PBS. Figures 6B and C show the expression 
level of Runx2 and Osteocalcin genes (osteogenic genes) of cells in the hydrogels implanted. 
Similarly to the results of Cxcr4 expression, a significantly up-regulated Runx2 expression 
was found in every hydrogel group 2 and 4 weeks after implantation. Implantation of 
hydrogels incorporating combined SDF-1 and BMP-2 resulted in a significantly up-regulated 
Runx2 gene than that of the hydrogels incorporating PBS or BMP-2 4 weeks later. 
Apparently, the Osteocalcin expression of cells in the hydrogels incorporating combined 
SDF-1 and BMP-2 implanted was significantly higher than that of every hydrogel group both 
the 2 (50-fold increase) and 4 weeks (1,000-fold increase) after implantation. 
 
3.5 Ectopic bone tissue formation 
 Figure 7 shows the soft x-ray and histological images of bone tissue formation at the 
subcutaneous site. The ectopic formation of bone tissues was observed for hydrogels 
incorporating combined SDF-1 and BMP-2 or BMP-2. The combined SDF-1 and BMP-2 
incorporated in the hydrogels generated a larger area of bone tissue formation than the BMP-
2-incorporated hydrogels. In contrast, only a slight amount of calcification (white area) was 
observed in the hydrogels incorporating SDF-1 or PBS. Comparing with the corresponding 




































































SDF-1 and BMP-2 induced the larger formation of matured bone tissue (stained as dark pink 
and blue), followed by the BMP-2 group. On the other hand, a low density of collagen was 
observed in both the hydrogels incorporating SDF-1 and PBS. Figure 7E shows the area 
percentage of matured collagen to collagen newly formed. The percentage of matured 
collagen was significantly higher for the hydrogels incorporating SDF-1 and BMP-2 than that 
of hydrogels incorporating BMP-2. 
 
3.6 Cell recruitment to the tissue around the site of hydrogels incorporating SDF-1 and/or 
BMP-2 implanted 
 Figure 8 shows immunohistochemical staining images of cells recruited into the 
tissue around the site of hydrogels implanted.  At 2 weeks, more GFP-positive-bone marrow-
derived cells were recruited and accumulated around the interface of hydrogels incorporating 
SDF-1, BMP-2, and combined SDF-1 and BMP-2, in contrast to that of hydrogels 
incorporating PBS. Figure 8E shows the percentage of GFP-positive cells to total cells 
recruited into the tissue around hydrogels implanted. Only the hydrogels incorporating 
combined SDF-1 and BMP-2 showed significantly higher percentage of GFP-positive cells to 
the total cells, when compared with that of the hydrogels incorporating PBS. At 4 weeks, in 
addition to the GFP-positive cells, osteocalcin-positive cells were also found inside and 
around the hydrogels incorporating combined SDF-1 and BMP-2 or BMP-2 implanted. A 
good merge of GFP- and osteocalcin-positive cells localization (yellow) was detected for 
both the hydrogel groups. However, the higher density of osteocalcin-positive cells was 
found in the hydrogels incorporating combined SDF-1 and BMP-2 than that of the hydrogels 
incorporating BMP-2.  
 Figure 9 shows the immunohistochemistry staining images of CD31- and CD34-




































































incorporating combined SDF-1 and BMP-2 or BMP-2, CD31- and CD34-positive cells were 
accumulated. In addition, a vascular-like structure was observed for both the hydrogel 
groups, particularly around the hydrogels. 
 
3.7 The fraction type of non-hematopoietic stem cells recruited in gelatin hydrogels 
incorporating SDF-1 and/or BMP-2 implanted  
 Figure 10A shows the flow cytometric profiles and histograms of cells detected in 
gelatin hydrogels 4 weeks after implantation. The high density of CD45-positive cells were 
found in every hydrogel implanted whereas the CD45-negative and CD44-positive cells were 
remarkably seen only in the hydrogels incorporating combined SDF-1 and BMP-2 (square 
gates). In addition, in the fraction of CD45-negative and CD44-positive cells, a number of 
CD29-positive cells were obviously detected in the hydrogels incorporating combined SDF-1 
and BMP-2. Figures 10B - D show the number and percentage of targeted cells analyzed 
from the profiles and histograms above. The similar trend was found for the total number of 
live cells, the percentage of CD45-negative and CD44-positive cells to total live cells, and the 
percentage of CD45-negative, CD44-positive, and CD29-positive cells to total live cells. 
Gelatin hydrogels incorporating combined SDF-1 and BMP-2 tended to increase the number 
of live cells, and showed significantly enhanced fraction number of CD45-negative, CD44-
positive, and CD29-positive cells, compared with those incorporating PBS, SDF-1, and 
BMP-2, respectively. The largest number percentage of CD45-negative and CD44-positive 
cells to total live cells was observed for the hydrogels incorporating combined SDF-1 and 









































































Natural bone regeneration is a complex process in which hematopoietic and bone 
progenitor cells are regulated by a number of environmental stimuli to coordinately function 
for osteogenesis. In this study, the system of gelatin hydrogels for combined release of SDF-1 
and BMP-2 synergistically enhanced bone regeneration. SDF-1 has an inherent ability to 
enhance the recruitment of hematopoietic cells [14-17] and BMP-2 has a potential to promote 
the osteogenic differentiation of bone progenitor cells [20,21] and to recruit the cells [8,9]. If 
the release of two protein factors works well, it is theoretically possible that the recruitment 
of hematopoietic and bone progenitor cells will be promoted. The former cells will generate 
new blood vessels while the latter cells will be differentiated by BMP-2 action, resulting an 
enhanced bone regeneration. The present study experimentally confirmed that the story works 
well through the combined release of SDF-1 and BMP-2 with the gelatin hydrogels. 
Our previous researches have demonstrated that the hydrogels prepared from gelatin 
with IEP 9.0 could release SDF-1 or BMP-2 in a controlled fashion [9,18]. Therefore, in this 
study, the same gelatin hydrogels were selected for the combined release of SDF-1 and BMP-
2. The in vivo release test revealed that the initial release of SDF-1 was accelerated by the 
BMP-2 combination, but the BMP-2 release was not influenced by the SDF-1 combination. 
This phenomenon is explained by the viewpoint of interaction forces between the molecules 
to be released and the material of release carrier. The interaction between the BMP-2 and 
gelatin is stronger than that of SDF-1 and gelatin. The BMP-2 combination would weaken the 
interaction force of SDF-1. In the other words, the co-presence of BMP-2 in the hydrogels 
decreases the site of gelatin to interact with SDF-1, resulting in a large amount of initial 
diffusional SDF-1 release. Several studies have reported on difference in the release behavior 




































































indomethacin from a heparin-conjugated polymeric micelle was suppressed by the 
combination of basic fibroblast growth factor (bFGF) whereas the indomethacin combination 
did not affect the profile of bFGF release [32]. This result was also explained in terms of the 
interaction force. In addition, after 14 days of implantation, the remaining amount of BMP-2 
in the hydrogels was more than that of the SDF-1, implying a more controlled manner of 
BMP-2 than SDF-1, which corresponded to the results reported previously [9,18]. When the 
release profile of SDF-1 or BMP-2 was plotted against that of gelatin hydrogel degradation, a 
good correlation between the two profiles was observed. It is conceivable that the 
mechanisms of SDF-1 and BMP-2 release from the gelatin hydrogels were in the diffusion or 
carrier degradation manners. SDF-1 and BMP-2 would be initially burst released from the 
hydrogels by the diffusion mechanism. After that, they were released by the degradation of 
gelatin hydrogels. The carriers with an optimal degradation profile will contribute to the 
optimal sustained release of growth factors incorporated to achieve growth factor-induced 
bone regeneration. In addition to the profile of growth factors release, bone tissue formation 
is also influenced by the degradation profile of carrier itself [34]. Slow-degraded carriers 
physically hindered the process of bone formation and biochemically impaired the matrix 
deposition, resulted in minimal bone formation, while the extent of bone formation could be 
augmented by the carriers with an appropriate degradability [35]. Based on the finding in this 
study, the gelatin hydrogels with in vivo biodegradation for 4-5 weeks was selected for bone 
regeneration [9]. 
To investigate the biological effects of SDF-1 and BMP-2 for MSC, the gene 
expression was evaluated. No influence of SDF-1/BMP-2 mixing ratio on the level of Cxcr4 
and Runx2 gene expression and the ALP activity was observed (Figure 1). Any combination 
of SDF-1 and BMP-2 or BMP-2 up-regulated both the Cxcr4 and Runx2 expression. This 




































































pathway) and osteogenic differentiation (via the activation of Runx2 pathway) of MSC in 
vitro [36]. SDF-1 is one ligand of Cxcr4 on the cell surface, so it does not change the level of 
Cxcr4 expression [37]. Our previous researches reported that a single delivery of 5 µg of 
SDF-1 and 3 µg of BMP-2 was effective in enhancing in vivo angiogenesis and bone 
regeneration, respectively [9,18]. Thus, in our combined SDF-1/BMP-2 system, it is highly 
possible to consider that the mixing ratio of SDF-1/BMP-2 affects the biological activity. 
However, a significant difference among the mixing ratios was not found in this study. Based 
on the previous findings, the 500/300 mixing ratio of SDF-1/BMP-2 was then selected for the 
hydrogel incorporation system. For MSC cultured in the hydrogels incorporating combined 
SDF-1 and BMP-2, the cell response was quite different from that of the factors without the 
hydrogel incorporating. A significantly high up-regulation of Runx2 gene was observed 
compared with the hydrogels incorporating BMP-2. It may be explained that the gelatin 
hydrogels was effective in prolonging the half-life of SDF-1 and BMP-2 and the 
consequently enhanced their biological activities for cells [38]. 
Gelatin hydrogels incorporating combined SDF-1 and BMP-2 revealed a significant 
great potential to induce bone regeneration at both the bone defect and subcutaneous site. The 
level of Osteocalcin gene expression of cells in the hydrogels implanted was substantially up-
regulated (> 1,000-fold) (Figure 6E). Osteocalcin-positive cells were accumulated around the 
hydrogels implanted (Figure 8C). In addition, the fraction of non-hematopoietic cells (CD45-
negative, CD44-positive, and CD29-positive) which may contain mesenchymal stem cells, 
was apparently detected (Figure 10). Taken together, it is likely that the combined release of 
SDF-1 and BMP-2 enhanced the number of cells recruited and their osteogenic differentiation 
thereat. Consequently, the biological event would result in enhanced bone regeneration. The 
molecular mechanism regulating the osteogenic differentiation and bone regeneration by the 




































































reasons to support this synergistic phenomenon. The first possible reason is the enhancement 
of cell recruitment by both the SDF-1 and BMP-2 through SDF-1/CXCR4 or other signals 
[12-14,39]. It is well recognized that SDF-1 plays a critical role in the recruitment of bone 
marrow-derived cells including hematopoietic and mesenchymal stem cells, together with 
inflammatory cells to the site of SDF-1 present [10-16]. The recruited cells would secret a 
number of cytokines and growth factors which are necessary to proceed the natural process of 
tissue regeneration and healing [40]. BMP-2 is also reported to have a property to induce the 
recruitment of many types of cells [39,41]. It has been demonstrated that BMP-2 released 
from the gelatin hydrogels could recruit bone marrow-derived cells via the activation of 
placental growth factor (PlGF) pathway [9]. The enhanced expression of PlGF consequently 
promoted the recruitment of progenitor cells from the bone marrow [42-44]. In this study, it 
is experimentally confirmed on the chemotactic effect of combined SDF-1 and BMP-2 
system on the GFP-positive-bone marrow-derived stem cells in the Chimeric mouse model. 
In addition, the higher number of live cells and non-hematopoietic stem cells was detected in 
the hydrogels incorporating combined SDF-1 and BMP-2 implanted, compared with that of 
other hydrogels (Figures 10B - D). Taken together, the enhanced recruitment of bone 
marrow-derived mesenchymal stem cells together with the other types of cells by the 
combined SDF-1 and BMP-2 system would be one of the key factors contributing to the 
accelerated bone regeneration. 
The second reason would be the enhanced angiogenesis as a result of the enhanced 
recruitment of hematopoietic stem cells, which may be committed to endothelial cells. It is 
well known that the local presence of blood vessels is necessary for wound healing and bone 
regeneration [45]. Many researchers have demonstrated that angiogenesis was enhanced by 
vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) family, and other 




































































angiogenic growth factors [48,49]. Schantz et al. [50] examined the homing of mesenchymal 
stem cells by SDF-1 treatment with an infusion pump in vivo. It was shown that the 
combination of VEGF, SDF-1, and BMP-6 was effective in inducing vascularization in a 
poly(caprolactone) scaffold. In addition, a recent research has reported on the role of SDF-1 
in the modulating inflammation response by the participation of the recruited stem cells, 
providing a suitable environment for the materials implanted and subsequent guiding an 
angiogenesis and wound healing [51]. We have demonstrated that the gelatin hydrogels 
enabled SDF-1 to locally release, resulting in an enhanced vascularization at the site 
implanted [18]. In this study, an enhanced number of CD31- and CD34-positive cells 
accumulated around gelatin hydrogels incorporating SDF-1, in remarked contrast to the 
hydrogels incorporating PBS. The combined SDF-1 and BMP-2 or BMP-2 release strongly 
increased the accumulation of positive cells. It is reported that BMP-2 also exhibits an 
angiogenetic nature [52-54]. Several researches claim that BMP-2 promoted angiogenesis 
through the stimulation of Smad 1/5, Erk 1/2, and Id expression [55,56]. The Id family of 
transcription factors to regulate the neovascularization has been identified as one of the main 
BMP-2 signaling pathways [57]. In addition, BMP-2 and BMP-4 induced the production of 
VEGF by different cells, contributing to the angiogenic response [57,58]. Furthermore, BMP-
2 might enhance angiogenesis through the chemotaxis of monocytes, which can secrete 
cytokines that promote the formation of blood vessels [59]. Considering the angiogenic 
property of SDF-1 and BMP-2 reported, it may be reasonable to show the highest expression 
of endothelial markers around the tissue of hydrogels incorporating SDF-1 and BMP-2 
implanted because of the combined angiogenic effect of SDF-1 and BMP-2. 
Third possible mechanism is the activation of osteogenic differentiation through the 
co-requirement of the SDF-1 and BMP-2 signaling axis. Zhu et al. [23] have demonstrated 




































































C2C12 and ST2 cells. The blocking of SDF-1 signaling before BMP-2 stimulation strongly 
suppressed the BMP-2-induced osteogenic differentiation. They revealed that the interaction 
between SDF-1 and BMP-2 signaling was mediated via the intracellular Smads and MAPK 
activation. In addition, it was shown that C2C12 cells treated with SDF-1 before BMP-2 
stimulation significantly enhanced osteocalcin synthesis. Hosogane et al. [24] have also 
reported a similar regulatory role of SDF-1 in BMP-2-induced osteogenic differentiation for 
human and mouse MSC. It is suggested that the SDF-1 effect was mediated via the 
intracellular Smad and Erk activation. The present study clearly indicated that the enhanced 
osteogenic differentiation of combined SDF-1 and BMP-2 was due to the highly up-regulated 
osteogenic gene expression, particularly Osteocalcin gene, of cells in the hydrogels 
subcutaneously implanted. Additionally, in the Chimeric mouse model, a number of 
osteocalcin-positive
 
cells were found in the hydrogels incorporating combined SDF-1 and 
BMP-2. Furthermore, the same localization of GFP-
 
and osteocalcin-positive cells was 
observed. This indicated that the combined SDF-1 and BMP-2 released by the hydrogels 
promoted the recruitment of bone marrow-derived mesenchymal stem cells and the 
subsequent enhancement of their osteogenic differentiation. In addition, the combined SDF-1 
and BMP-2 showed the synergistic effect to induce the presence of high expressing CD44 
and CD29 non-hematopoietic cells including the fraction of mesenchymal stem cells [31]. It 
is thus conceivable that the co-requirement of SDF-1 and BMP-2 for osteogenic 
differentiation may be a significant factor to achieve bone regeneration.  
Based on three mechanisms proposed, the synergistic effect of combined SDF-1 and 
BMP-2 release on the bone regeneration may be explained. This finding provides a novel 
controlled release system that simultaneously stimulates bone regeneration through the 
mechanism of cell recruitment, angiogenesis, and osteogenic diffentiation of body-originating 




































































augmented by modifying the release kinetics of multiple growth factors. For example, if 
multiple growth factors can release in a controlled and sequential manner, the release 




 The present study demonstrated that the combined release of SDF-1 and BMP-2 from 
gelatin hydrogels induced bone regeneration at both the critical-sized bone defect and 
subcutaneous site to a significantly great extent compared with a single release of SDF-1 or 
BMP-2. The synergistic effect of combined SDF-1 and BMP-2 release on the bone 
regeneration was explained through the mechanism of cell recruitment, angiogenesis, and 
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Figure 1. Gene expression of (A) Cxcr4 and (B) Runx2 and (C) ALP activity of MSC cultured with SDF-1, BMP-2, 
and the combination at different mixing ratios for 24 hr. The gene expression is normalized with the level of non-
treated MSC. * p < 0.05, significant against the value of non-treated MSC. 
Figure 2. Gene expression of (A) Cxcr4 and (B) Runx2 of MSC cultured in the gelatin hydrogels incorporating 
PBS, SDF-1, BMP-2, and the combination for 3 days. The gene expression is normalized with the level of MSC 
cultured in the hydrogels incorporating PBS. * p < 0.05, significant against the value of gelatin hydrogels 
incorporating PBS, † p < 0.05, significant against the value of gelatin hydrogels incorporating BMP-2. 





I-labeled BMP-2 after implantation into the back subcutis of C57BL/6 mice. the hydrogels incorporating 
5 µg of 
125
I-labeled SDF-1 (   ), 5 µg of 
125
I-labeled SDF-1 and 3 µg of non-labeled BMP-2 (   ), 5 µg of non-
labeled SDF-1 and 3 µg of
 125
I-labeled BMP-2 (   ), and 3 µg of
 125
I-labeled BMP-2 (   ) or 
125
I-labeled gelatin 
hydrogels (). * p < 0.05, significant against the value of gelatin hydrogels incorporating 125I-labeled SDF-1.           
(B) Relationship of remaining radioactivity between 
125
I-labeled SDF-1 or 
125
I-labeled BMP-2 incorporated in 
gelatin hydrogels and 
125
I-labeled hydrogels of release carriers.  
Figure 4. Soft X-ray and histological (H&E and Masson Trichrome staining) images  of bone regenerated in the 
ulna critical-sized defects of Wistar rats implanted with the gelatin hydrogels incorporating (A) PBS, (B) 5 µg of 
SDF-1, (C) 5 µg of SDF-1 and 3 µg of BMP-2, and (D) 3 µg of BMP-2 4 weeks post-operatively. (C: collagen, M: 
muscle, scale bar = 200 µm). 
Figure 5.  Three-dimensional CT images of bone regenerated in the ulna critical-sized defects of Wistar rats 
implanted with gelatin hydrogels incorporating (A) 5 µg of SDF-1 and 3 µg of BMP-2 and (B) 3 µg of BMP-2 4 
weeks post-operatively. (C) Bone mineral density of bone regenerated 4 weeks post-operatively, analyzed by 
pQCT. * p < 0.05, significant against the value of gelatin hydrogels incorporating BMP-2. 
Figure 6.  Gene expression of (A) Cxcr4, (B, C) Runx2, and (D, E) Osteocalcin of cells in the hydrogels 
incorporating PBS, 5 µg of SDF-1, 5 µg of SDF-1 and 3 µg of BMP-2, and 3 µg of BMP-2 3 days (A), 2 (B, D) and 
4 weeks (C, E) after implantation into the back subcutis of Wistar rats. The gene expression is normalized with 
the level of sham group. * p < 0.05, significant against the value of sham group. † p < 0.05, significant against  







Figure 7.  Soft X-ray and histological (H&E and Masson Trichrome staining) images of bone tissue formation at 
the back subcutis of Wistar rat implanted with gelatin hydrogels incorporating (A) PBS, (B) 5 µg of SDF-1, (C) 5 
µg of SDF-1 and 3 µg of BMP-2, and (D) 3 µg of BMP-2 4 weeks post-operatively. (C: collagen, MC: matured 
collagen, scale bar = 200 µm). (E) Percentage of matured collagen to collagen newly formed. * p < 0.05, 
significant against the value of gelatin hydrogels incorporating BMP-2. 
Figure 8. Immunohistochemical staining images of cells recruited into the tissue around the site implanted with 
gelatin hydrogels incorporating (A) PBS, (B) 5 µg of SDF-1, (C) 5 µg of SDF-1 and 3 µg of BMP-2, and (D) 3 µg 
of BMP-2 implanted into the back subcutis of GFP-positive Chimeric mice. The images were taken 2 (left and 
middle) and 4 weeks after implantation (right) (GFP-positive cells: green, osteocalcin-positive cells: red, scale bar 
= 200 µm). (E) Percentage of GFP-positive cells to total cells recruited into the tissue around hydrogels 
implanted. * p < 0.05, significant against the value of gelatin hydrogels incorporating PBS. 
Figure 9. Immunohistochemical staining images of CD31- (left) and CD34-positive cells (right) recruited into the 
tissue around the site implanted with gelatin hydrogels incorporating (A) PBS, (B) 5 µg of SDF-1, (C) 5 µg of 
SDF-1 and 3 µg of BMP-2, and (D) 3 µg of BMP-2 2 weeks after implantation into the back subcutis of GFP-
positive Chimeric mice (CD31- and CD34-positive cells: brown, cell nuclei: purple, scale bar = 100 µm). 
Figure 10. (A) Flow cytometric profiles of sort gates of CD45-negative and CD44-positive cells and histograms of 
CD45-negative, CD44-positive, and CD29-positive cells (B) Total number of live cells, (C) Percentage of CD45-
negative and CD44-positive cells to total cells, and (D) Percentage of CD45-negative, CD44-positive, and CD29-
positive cells to total cells in gelatin hydrogels incorporating PBS, 5 µg of SDF-1, 5 µg of SDF-1 and 3 µg of BMP-
2, and 3 µg of BMP-2 implanted into the back subcutis of C57BL/6 mice 4 weeks. * p < 0.05, significant against 
the value of gelatin hydrogels incorporating PBS. † p < 0.05, significant against the value of gelatin hydrogels 
incorporating SDF-1. ‡ p < 0.05, significant against the value of gelatin hydrogels incorporating BMP-2. 
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Table 1. Sequence of primers used for RT-PCR assay 
 
Gene Primer/probe Sequence 
Cxcr4 Forward CGAGCATTGCCATGGAAATATA 
 Reverse AGGTGCAGCCGGTACTTGTC 
Runx2 Forward CAAGTGGCCAGGTTCAACGA 
 Reverse GGGACCGTCCACTGTCACTTTAATA 
Osteocalcin Forward TGCAAAGCCCAGCGACTCT 
 Reverse TTGAGCTCACACACCTCCCTGT 
18S Forward ACTCAACACGGGAAACCTCA 





















                                      
 
                                    
 
        
           Figure 1. (Ratanavaraporn et al.) 
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A. Gelatin hydrogels incorporating PBS 
B. Gelatin hydrogels incorporating SDF-1 
C. Gelatin hydrogels incorporating SDF-1 and BMP-2 







                 
 
             Figure 5. (Ratanavaraporn et al.) 
A. Gelatin hydrogels incorporating SDF-1 and BMP-2 
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A. Gelatin hydrogels incorporating PBS 
B. Gelatin hydrogels incorporating SDF-1 
C. Gelatin hydrogels incorporating SDF-1 and BMP-2 
D. Gelatin hydrogels incorporating BMP-2 
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   Figure 8. (Ratanavaraporn et al.) 
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A. Gelatin hydrogels incorporating PBS 
B. Gelatin hydrogels incorporating SDF-1 
C. Gelatin hydrogels incorporating SDF-1 and BMP-2 
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B. Gelatin hydrogels incorporating SDF-1 
C. Gelatin hydrogels incorporating SDF-1 and BMP-2 
D. Gelatin hydrogels incorporating BMP-2 
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